(Q36697466)

15 August 2017

1 reference

title

Discovery of antiepileptic drugs (English)

1 reference

15 August 2017

Misty Smith

1

1 reference

15 August 2017

Karen S Wilcox

series ordinal

2

1 reference

15 August 2017

H Steve White

series ordinal

3

1 reference

15 August 2017

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

4

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

12-17

1 reference

https://scigraph.springernature.com/pub.10.1016/j.nurt.2006.11.009

15 August 2017

exact match

0 references

cites work

Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

Comparison of the effect of glutamate receptor modulators in the 6 Hz and maximal electroshock seizure models

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

Use of chronic epilepsy models in antiepileptic drug discovery: the effect of topiramate on spontaneous motor seizures in rats with kainate-induced epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

Differential effects mediated by GABAA receptors in thalamic nuclei in lh/lh model of absence seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.009

Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy

21 January 2018

1 reference

12 December 2020

Responses to NMDA receptor antagonists altered by epileptogenesis

1 reference

12 December 2020

Effects of antiepileptic drugs on induced epileptiform activity in a rat model of dysplasia

1 reference

12 December 2020

Pharmacological models of generalized absence seizures in rodents

1 reference

12 December 2020

Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy

1 reference

12 December 2020

Comparative assay of an antiepileptic drugs by psychomotor seizure test and minimal electroshock threshold test

1 reference

12 December 2020

EXPERIMENTAL DETERMINATION OF THE ANTICONVULSANT PROPERTIES OF SOME PHENYL DERIVATIVES

1 reference

12 December 2020

Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop

1 reference

12 December 2020

Animal models used in the screening of antiepileptic drugs

1 reference

12 December 2020

The National Institutes of Health Anticonvulsant Drug Development Program: screening for efficacy

1 reference

12 December 2020

Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy

1 reference

12 December 2020

The petit mal epilepsies; their treatment with tridione

1 reference

12 December 2020

Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures

1 reference

12 December 2020

Anticonvulsant efficacy and adverse effects of phenytoin during chronic treatment in amygdala-kindled rats.

1 reference

12 December 2020

Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds

1 reference

12 December 2020

Genetic Absence Epilepsy in Rats from Strasbourg (GAERS)

1 reference

12 December 2020

10.1016/J.NURT.2006.11.009

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1013087044

0 references

1 reference